Literature DB >> 18753942

Nodular amiodarone lung disease.

Ruchira Ruangchira-Urai1, Thomas V Colby, Julianne Klein, G Petur Nielsen, Richard L Kradin, Eugene J Mark.   

Abstract

The antiarrhythmic drug amiodarone accumulates in many organs of the body. Amiodarone lung disease (ALD) most commonly manifests clinically as an interstitial pneumonitis. The few reports of nodular ALD generally have been in the clinical and radiographic literature. No detailed histopathologic analysis of nodular ALD is available. We report 4 patients with nodular ALD, all of whom had excision of a nodule and none had a preoperative diagnosis of ALD. The radiographic suspicion before excisional biopsy in all 4 cases was malignancy. The initial pathologic suspicion in all 4 cases was either an abscess or vasculitis. In 3 of the 4 cases, where the dosages were known, each patient received 800 mg/d for 7 or more months. All cases have strikingly similar histopathology, with vacuolated histiocytes massed within alveoli to form macroscopic nodules with tissue breakdown. Ultrastructural examination of lung and peripheral nerve in 1 case showed the characteristic inclusions of amiodarone in the cytoplasm of swollen histiocytes. Vacuolated histiocytes filled with these inclusions indicate the effect of the drug, but in these 4 cases there was tissue destruction, which indicated disease. The necrotizing nature of the massed histiocytes in the absence of infection or obstruction suggests the correct etiologic diagnosis even when the history of administration of the drug is not available at initial review.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18753942     DOI: 10.1097/PAS.0b013e31816d1cbc

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  5 in total

Review 1.  Amiodarone-induced pulmonary toxicity: an under-recognized and severe adverse effect?

Authors:  Martin Schwaiblmair; Thomas Berghaus; Thomas Haeckel; Theodor Wagner; Wolfgang von Scheidt
Journal:  Clin Res Cardiol       Date:  2010-07-10       Impact factor: 5.460

Review 2.  Amiodarone: review of pulmonary effects and toxicity.

Authors:  Spyros A Papiris; Christina Triantafillidou; Likurgos Kolilekas; Despoina Markoulaki; Effrosyni D Manali
Journal:  Drug Saf       Date:  2010-07-01       Impact factor: 5.606

3.  Intracellular sequestration of amiodarone: role of vacuolar ATPase and macroautophagic transition of the resulting vacuolar cytopathology.

Authors:  G Morissette; A Ammoury; D Rusu; M C Marguery; R Lodge; P E Poubelle; F Marceau
Journal:  Br J Pharmacol       Date:  2009-07-07       Impact factor: 8.739

4.  Amiodarone-related pneumonitis and peripheral neuropathy in an elderly patient.

Authors:  Nirmala Rosseti; Leonardo Calza; Benedetta Piergentili; Alessandra Cascavilla; Fabio Filippo Trapani; Andrea Berlingeri; Ginevra Marinacci; Luciano Attard; Gabriella Verucchi
Journal:  Aging Clin Exp Res       Date:  2010 Oct-Dec       Impact factor: 3.636

5.  Amiodarone hepatotoxicity with absent phospholipidosis and steatosis: a case report and review of amiodarone toxicity in various organs.

Authors:  Adela Cimic; Joseph Sirintrapun
Journal:  Case Rep Pathol       Date:  2013-05-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.